Question 1

Does Farallon Capital Management own BBIO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Farallon Capital Management holds 10,743,063 shares of BBIO (Bridgebio Pharma), worth $800.1M.

Question 2

How many shares of BBIO does Farallon Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Farallon Capital Management holds 10,743,063 shares of BBIO (Bridgebio Pharma).

Question 3

What is Farallon Capital Management's BBIO position worth?

Accepted Answer

As of its Q2 2026 13F, Farallon Capital Management's BBIO position is worth $800.1M.

Question 4

Is Farallon Capital Management buying or selling BBIO?

Accepted Answer

In Q2 2026, Farallon Capital Management increased its BBIO position by 1,377,600 shares (+14.7%).

Question 5

When did Farallon Capital Management first buy BBIO?

Accepted Answer

Farallon Capital Management first reported BBIO in its Q4 2023 13F and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	10.7M	+14.7%	$800.1M	3.7%	$74.48	67
2026-Q1	Increased	9.4M	+4.1%	$695.5M	3.6%	$74.26	60
2025-Q4	Increased	9M	+9.8%	$688.3M	3.0%	$76.49	60
2025-Q3	Increased	8.2M	+3.7%	$425.5M	1.7%	$51.94	51
2025-Q2	Increased	7.9M	+37.9%	$341.1M	1.4%	$43.18	64
2025-Q1	Increased	5.7M	+36.6%	$198.1M	1.0%	$34.57	56
2024-Q4	Increased	4.2M	+140.1%	$115.1M	0.5%	$27.44	68
2024-Q3	New	1.7M	-	$44.5M	0.2%	$25.46	48
2024-Q1	Exited	0	-100.0%	$0	0.0%	$30.92	0
2023-Q4	New	6,000	-	$242,220	0.0%	$40.37	32

BBIO10 quarters

BBIO
10 quarters